Multi-receptor targeted therapy of breast cancer and brain metastases with a novel QUAD-drug conjugate
{{output}}
Background: Identifying treatments for triple-negative breast cancer (TNBC) remains a critical medical need. We have found that Interleukin 13 receptor alpha 2 (IL-13RA2), EphA2, EphA3 and EphB2 receptors are over-expressed colle... ...
